News | News By Subject | News by Disease News By Date | Search News

Alzheimer's Disease News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News
Watch Out Gilead (GILD), Investors Feel Vertex (VRTX) May Be Biogen (BIIB)'s Good Fit     7/31/2015
Embattled Vitae Pharma (VTAE) and Boehringer Ingelheim Relationship Takes Another Blow, Drops BACE Inhibitor Program for Alzheimer’s     7/27/2015
Biogen (BIIB) and Eli Lilly (LLY)’s Alzheimer’s Drugs Hint At Promise, But Fail To Dazzle     7/23/2015
As Biogen (BIIB), Eli Lilly (LLY) Fall Short, Roche (RHHBY) Intensifies Work on Two Alzheimer's Drugs     7/23/2015
Investors Excited Over Eli Lilly (LLY) and Biogen (BIIB)'s Upcoming Alzheimer’s Drug Data     7/21/2015
Why All Eyes Will Be on Biogen (BIIB)'s Alzheimer's Data Next Week     7/20/2015
Executive Shuffle and Alzheimer’s Drug Report Creates a Rocky Road for Biogen (BIIB) Stock     7/14/2015
AB Science (AB.PA) Studies Banned in France Due to Side Effects     7/9/2015
Evotec AG (EVTG.F), Roche (RHHBY)'s Alzheimer's Hopeful Fails Another Trial     7/2/2015
Eli Lilly (LLY) Hits 14-Year High as Investors Await Alzheimer's Data     6/16/2015
Buoyed by Biogen (BIIB), Roche (RHHBY) to Take Another Stab at Anti-Amyloid Alzheimer’s Drugs     6/10/2015
Actavis (ACT) Ordered to Keep Older Alzheimer’s Drug Namenda on the Market     5/26/2015
FORUM Pharma Consolidates Operations in Anticipation of New Growth     5/19/2015
Advancing Biogen (BIIB)’s Alzheimer’s Treatment Could Cost $2.5 Billion Before Knowing if the Drug Works     4/28/2015
In Fight Against Alzheimer's, $100 Million Genentech (RHHBY) Trial in Colombia May Be Ground Zero     4/28/2015

News from Around the Web
Upping Your Coffee Intake May Be Bad For The Brain, University of Bari Study     7/29/2015
High Blood Sugar May Up Alzheimer’s Disease Risk, New Iowa State University Study Finds     7/28/2015
Too Much TV Could Raise Your Alzheimer’s Risk, Northern California Institute for Research and Education Study Suggests     7/21/2015
New Ways To Predict The Alzheimer's Disease Development Reported, Alzheimer's Association Study     7/21/2015
Battle Erupts Over Poached Researcher     7/20/2015
Genetic Markers Linking Risk For Type 2 Diabetes And Alzheimer's ID'd, Mount Sinai School of Medicine Study     7/17/2015
Beth Israel Deaconess Medical Center Scientists Develop Antibody To Treat Traumatic Brain Injury And Prevent Long-Term Neurodegeneration     7/16/2015
Enriched Blood Cells Preserve Cognition In Mice With Features Of Alzheimer's Disease, Cedars-Sinai Medical Center Study     7/8/2015
Midlife Changes In Alzheimer’s Biomarkers May Predict Dementia, Washington University in St. Louis Study     7/7/2015
University of Southern California Scientists Look Into Why Most Alzheimer's Patients Are Women     6/29/2015
Middle Age Memory Failures Can Predict Alzheimer's 18 Years Before Diagnosis, Rush University Medical Center Study     6/29/2015
High Blood Pressure Linked To Lower Alzheimer's Risk, Brigham Young University Study     6/29/2015
Blood Type May Boost Alzheimer's Risk, University of Sheffield Study     6/5/2015
DNA Breakage Underlies Both Learning, Age-Related Damage, MIT Study     6/5/2015
Poor Sleep Linked To Alzheimer’s, University of California, Berkeley (CAL) Study     6/3/2015

Press Releases
Encouraging Results Of AXON's Tau Vaccine Advance Alzheimer's Therapy     7/23/2015
Alzheimer's Association Release: Going Beyond Risk Reduction: Physical Exercise May Be An Effective Treatment For Alzheimer's Disease And Vascular Dementia     7/23/2015
AVANIR Pharmaceuticals (AVNR) Announces New Findings From Dementia/Alzheimer's Disease Cohort Of PRISM II Study At Alzheimer's Association International Conference     7/23/2015
Amarantus Diagnostics Meets Primary And Secondary Endpoints In Blinded, Multi-Center LP-002 Clinical Study For Lympro(R) Blood Diagnostic For Alzheimer's Disease And Confirms Lympro's Fit-For-Purpose Use In Clinical Trials At The 2015 Alzheimer's Association International     7/23/2015
Clinical Trials Results And New Data Analyses In Amyloid-related Therapies From The Alzheimer's Association International Conference 2015     7/22/2015
Eli Lilly (LLY) Release: Data Using New Delayed-Start Methodology Suggested Benefit Of Early Treatment With Solanezumab In Patients With Mild Alzheimer's Disease     7/22/2015
New Data Presented At The 2015 Alzheimer's Association International Conference Include Three Reports Of Clinical Trials Targeting Cognition, Agitation, Patient Management     7/22/2015
Anavex (AVXL) Presents Positive Initial Phase IIa Study Data With ANAVEX 2-73 Showing Early Evidence Of Improving Cognition In Patients With Alzheimer’s Disease At AAIC 2015     7/22/2015
Biogen (BIIB) Presents New Data From Phase IB Study Of Investigational Alzheimer’s Disease Treatment Aducanumab (BIIB037) At Alzheimer’s Association International Conference 2015     7/22/2015
Cambridge Cognition Ltd Release: Breakthroughs In Measuring Efficacy Of Alzheimer’s Treatments: Opportunities Increase With Cloud Technology     7/22/2015
NYU Langone Medical Center Release: Novel Monoclonal Antibodies Show Promise For Alzheimer's Disease Treatment     7/21/2015
TREVENTIS Pre Clinical Candidate TRV 101 Demonstrates Significant Reduction In Both Amyloid Beta And Tau Toxic Aggregates In Animal Models Of Alzheimer's Disease     7/20/2015
NeuroPhage Pharmaceuticals, Inc.'s NPT088 Universally Targets Misfolded Proteins In Preclinical Studies Highlighted In Oral Session At The Alzheimer's Association International Conference     7/20/2015
Alzheimer's Association Release: Promising New Treatments For Alzheimer's Target Multiple Disease-Related Proteins; May Have Benefits For Several Brain Diseases     7/20/2015
University of California, Davis (UCD) Alzheimer's Researchers At Core Of Leading-Edge Dementia Discoveries     7/17/2015